These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 29256263)

  • 1. IL-17 and related cytokines involved in systemic sclerosis: Perspectives.
    Gonçalves RSG; Pereira MC; Dantas AT; Almeida AR; Marques CDL; Rego MJBM; Pitta IR; Duarte ALBP; Pitta MGR
    Autoimmunity; 2018 Feb; 51(1):1-9. PubMed ID: 29256263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-17 and Th17 cells in systemic sclerosis: a comprehensive review.
    Bălănescu P; Bălănescu E; Bălănescu A
    Rom J Intern Med; 2017 Dec; 55(4):198-204. PubMed ID: 28704201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cell abnormalities in systemic sclerosis with a focus on Th17 cells.
    Brembilla NC; Chizzolini C
    Eur Cytokine Netw; 2012; 23(4):128-39. PubMed ID: 23360781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated frequencies of CD4(+) IL-21(+) T, CD4(+) IL-21R(+) T and IL-21(+) Th17 cells, and increased levels of IL-21 in bleomycin-induced mice may be associated with dermal and pulmonary inflammation and fibrosis.
    Lei L; He ZY; Zhao C; Sun XJ; Zhong XN
    Int J Rheum Dis; 2016 Apr; 19(4):392-404. PubMed ID: 25545680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Th17 cells and IL-17 promote the skin and lung inflammation and fibrosis process in a bleomycin-induced murine model of systemic sclerosis.
    Lei L; Zhao C; Qin F; He ZY; Wang X; Zhong XN
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):14-22. PubMed ID: 26750756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression and significance of Th17 cells and related cytokines in a murine model of systemic sclerosis].
    Lei L; Zhong XN; Zhao C; Mi CD; Li JQ; Zeng JJ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Apr; 44(2):259-64. PubMed ID: 22517000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastric Juice Expression of Th-17 and T-Reg Related Cytokines in Scleroderma Esophageal Involvement.
    Nicola S; Rolla G; Bucca C; Geronazzo G; Ridolfi I; Ferraris A; Fusaro E; Peroni CL; Dughera L; Brussino L
    Cells; 2020 Sep; 9(9):. PubMed ID: 32947843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New insights into CD4(+) T cell abnormalities in systemic sclerosis.
    Liu M; Wu W; Sun X; Yang J; Xu J; Fu W; Li M
    Cytokine Growth Factor Rev; 2016 Apr; 28():31-6. PubMed ID: 26724976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The elevated expression of Th17-related cytokines and receptors is associated with skin lesion severity in early systemic sclerosis.
    Zhou Y; Hou W; Xu K; Han D; Jiang C; Mou K; Li Y; Meng L; Lu S
    Hum Immunol; 2015 Jan; 76(1):22-9. PubMed ID: 25500255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential roles of interleukin-17A in the development of skin fibrosis in mice.
    Okamoto Y; Hasegawa M; Matsushita T; Hamaguchi Y; Huu DL; Iwakura Y; Fujimoto M; Takehara K
    Arthritis Rheum; 2012 Nov; 64(11):3726-35. PubMed ID: 22833167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imbalance between T helper 17 and regulatory T cell subsets plays a significant role in the pathogenesis of systemic sclerosis.
    Mo C; Zeng Z; Deng Q; Ding Y; Xiao R
    Biomed Pharmacother; 2018 Dec; 108():177-183. PubMed ID: 30219674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is there a role for IL-17 in the pathogenesis of systemic sclerosis?
    Chizzolini C; Dufour AM; Brembilla NC
    Immunol Lett; 2018 Mar; 195():61-67. PubMed ID: 28919455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-21 induction of CD4+ T cell differentiation into Th17 cells contributes to bleomycin-induced fibrosis in mice.
    Lei L; Zhong XN; He ZY; Zhao C; Sun XJ
    Cell Biol Int; 2015 Apr; 39(4):388-99. PubMed ID: 25492803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased frequency of Th17 cells in systemic sclerosis is related to disease activity and collagen overproduction.
    Yang X; Yang J; Xing X; Wan L; Li M
    Arthritis Res Ther; 2014 Jan; 16(1):R4. PubMed ID: 24398084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activated and resting regulatory T cell exhaustion concurs with high levels of interleukin-22 expression in systemic sclerosis lesions.
    Mathian A; Parizot C; Dorgham K; Trad S; Arnaud L; Larsen M; Miyara M; Hié M; Piette JC; Frances C; Yssel H; Amoura Z; Gorochov G
    Ann Rheum Dis; 2012 Jul; 71(7):1227-34. PubMed ID: 22696687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-17 and interleukin-23: importance in the pathogenesis of lung impairment in patients with systemic sclerosis.
    Olewicz-Gawlik A; Danczak-Pazdrowska A; Kuznar-Kaminska B; Gornowicz-Porowska J; Katulska K; Trzybulska D; Batura-Gabryel H; Silny W; Poplawski D; Hrycaj P
    Int J Rheum Dis; 2014 Jul; 17(6):664-70. PubMed ID: 24467649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostaglandin I(2) analogues enhance already exuberant Th17 cell responses in systemic sclerosis.
    Truchetet ME; Allanore Y; Montanari E; Chizzolini C; Brembilla NC
    Ann Rheum Dis; 2012 Dec; 71(12):2044-50. PubMed ID: 22814427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disease Manifestation and Inflammatory Activity as Modulators of Th17/Treg Balance and RORC/FoxP3 Methylation in Systemic Sclerosis.
    Almanzar G; Klein M; Schmalzing M; Hilligardt D; El Hajj N; Kneitz H; Wild V; Rosenwald A; Benoit S; Hamm H; Tony HP; Haaf T; Goebeler M; Prelog M
    Int Arch Allergy Immunol; 2016; 171(2):141-154. PubMed ID: 27902985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of Th17 cells and CD4⁺CD25⁺ regulatory T cells with clinical parameters in patients with systemic sclerosis.
    Jiang N; Li M; Zeng X
    Chin Med J (Engl); 2014; 127(20):3557-61. PubMed ID: 25316229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Higher levels of serum interleukin-35 are associated with the severity of pulmonary fibrosis and Th2 responses in patients with systemic sclerosis.
    Tang J; Lei L; Pan J; Zhao C; Wen J
    Rheumatol Int; 2018 Aug; 38(8):1511-1519. PubMed ID: 29846790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.